An Overview of the Dry Eye Disease in Sjögren's Syndrome Using Our Current Molecular Understanding
KY Wu, M Kulbay, C Tanasescu, B Jiao… - International Journal of …, 2023 - mdpi.com
Sjögren's syndrome is a chronic and insidious auto-immune disease characterized by
lymphocyte infiltration of exocrine glands. The patients typically present with ocular surface …
lymphocyte infiltration of exocrine glands. The patients typically present with ocular surface …
The involvement of innate and adaptive immunity in the initiation and perpetuation of sjögren's syndrome
C Chivasso, J Sarrand, J Perret, C Delporte… - International journal of …, 2021 - mdpi.com
Sjogren's syndrome (SS) is a chronic autoimmune disease characterized by the infiltration of
exocrine glands including salivary and lachrymal glands responsible for the classical dry …
exocrine glands including salivary and lachrymal glands responsible for the classical dry …
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome
P Soret, C Le Dantec, E Desvaux, N Foulquier… - Nature …, 2021 - nature.com
There is currently no approved treatment for primary Sjögren's syndrome, a disease that
primarily affects adult women. The difficulty in developing effective therapies is-in part …
primarily affects adult women. The difficulty in developing effective therapies is-in part …
Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised …
EHM van der Heijden, SLM Blokland… - The Lancet …, 2020 - thelancet.com
Summary Background Primary Sjögren's syndrome is a systemic autoimmune disease
characterised by secretory gland dysfunction, for which no effective therapy is available …
characterised by secretory gland dysfunction, for which no effective therapy is available …
[PDF][PDF] One year in review 2020: pathogenesis of primary Sjögren's syndrome
M Bombardieri, OD Argyropoulou, F Ferro… - Clin Exp …, 2020 - clinexprheumatol.org
The pathogenesis of primary Sjögren's syndrome (pSS) remains poorly understood.
However, important efforts have been made during the last few months. In this review …
However, important efforts have been made during the last few months. In this review …
Plasmacytoid dendritic cells in the eye
A Jamali, B Kenyon, G Ortiz, A Abou-Slaybi… - Progress in retinal and …, 2021 - Elsevier
Plasmacytoid dendritic cells (pDCs) are a unique subpopulation of immune cells, distinct
from classical dendritic cells. pDCs are generated in the bone marrow and following …
from classical dendritic cells. pDCs are generated in the bone marrow and following …
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Objectives To systematically review the literature for assay methods that aim to evaluate type
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …
I interferon (IFN-I) pathway activation and to harmonise-related terminology. Methods Three …
Early diagnosis and treatment for Sjögren's syndrome: current challenges, redefined disease stages and future prospects
B Wang, S Chen, Q Zheng, Y Li, X Zhang, J Xuan… - Journal of …, 2021 - Elsevier
There are some challenges and unmet needs in the early diagnosis and management of
Sjögren's syndrome (SjS) such as prominent glandular dysfunction at diagnosis and long …
Sjögren's syndrome (SjS) such as prominent glandular dysfunction at diagnosis and long …
Transcriptomic and network analysis of minor salivary glands of patients with primary Sjögren's syndrome
A Oyelakin, E Horeth, EAC Song, S Min, M Che… - Frontiers in …, 2021 - frontiersin.org
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease characterized
primarily by immune-mediated destruction of exocrine tissues, such as those of the salivary …
primarily by immune-mediated destruction of exocrine tissues, such as those of the salivary …
The spectrum of extraglandular manifestations in primary sjögren's syndrome
Extraglandular manifestations (EGMs) in primary Sjogren's syndrome (pSS) represent the
clinical expression of the systemic involvement in this disease. EGMs are characterized by a …
clinical expression of the systemic involvement in this disease. EGMs are characterized by a …